Multi-Epitope-Based Vaccine Design Against Newcastle Disease Virus: Targeting Nucleoprotein Using Immunoinformatics
Futuristic Biotechnology · 31.03.2026 · 43-50
DOI: 10.54393/fbt.v6i1.232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Futuristic Biotechnology, online erschienen am 31.03.2026. Verfasst von Laraib Afzal Cheema und 2 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Avian paramyxovirus-1 (APMV-1) is the virus that causes Newcastle disease (ND), a highly infectious chicken illness that causes substantial financial losses globally.
Objectives
To retrieve the amino acid sequence of the nucleoprotein of APMV-1, identify immunogenic B-cell and T-cell epitopes, design a multi-epitope vaccine using suitable linkers and an adjuvant, and evaluate its interaction with chicken immune receptors along with immune response simulation.
Methods
The nucleoprotein sequence of NDV was retrieved from public databases. Immunoinformatic tools were used to predict B-cell and T-cell epitopes binding to MHC-I and MHC-II molecules. Selected epitopes were evaluated for antigenicity and allergenicity. The construct of the vaccine was designed by using the most antigenic 5 MHC-1, 4MHC-II, and all predicted B-cell epitopes of the NDV Nucleoprotein, along with suitable linkers, and by incorporating the B-subunit of the heat-labile enterotoxin (LTB) as an adjuvant. Interaction analysis with chicken immune receptors showed highly negative scores, which suggests strong and favorable binding between the vaccine construct and the TLR 4 receptor. Immune simulation was performed to assess the immunogenic potential of the construct.
Results
Several B-cell and T-cell epitopes with high antigenicity and favorable immunological properties were identified. These epitopes were assembled into a multi-epitope vaccine construct with suitable linkers and an adjuvant. Interaction analysis indicated stable binding with chicken immune receptors, and immune simulation predicted a strong immune response.
Conclusions
The designed multi-epitope vaccine shows potential as a candidate against Newcastle Disease, although experimental validation is required.
Zitieren
APA
Cheema, L. A., Iftikhar, A., & Lodhi, U. F. (2026). Multi-Epitope-Based Vaccine Design Against Newcastle Disease Virus: Targeting Nucleoprotein Using Immunoinformatics. Futuristic Biotechnology, 43-50. https://doi.org/10.54393/fbt.v6i1.232
Vancouver
Cheema LA, Iftikhar A, Lodhi UF. Multi-Epitope-Based Vaccine Design Against Newcastle Disease Virus: Targeting Nucleoprotein Using Immunoinformatics. Futuristic Biotechnology. 2026:43-50. doi:10.54393/fbt.v6i1.232
BibTeX
@article{Cheema2026,
author = {Cheema, Laraib Afzal and Iftikhar, Areebah and Lodhi, Umaima Fazal},
title = {Multi-Epitope-Based Vaccine Design Against Newcastle Disease Virus: Targeting Nucleoprotein Using Immunoinformatics},
journal = {Futuristic Biotechnology},
year = {2026},
pages = {43--50},
doi = {10.54393/fbt.v6i1.232}
}
EUVIMED